"In the current 2012 year Cuba will begin clinical trials of the latest pneumococcal vaccine, which was developed in the country," reported Xinhua. It is known that the authorship of the latest vaccine belongs to the staff of the Institute Finley (Havana, Cuba) and Center of biomolecular chemistry.
Pneumococcus is one of the most dangerous pathogens. This pathogen causes the development of such dangerous diseases as pneumonia, meningitis, sinusitis (primarily among the elderly, children and persons with severely weakened immune system).
Cuba currently is producing ten or more different vaccines. This number includes also vaccines against such diseases as hepatitis b, the first vaccine therapist against lung cancer, the pentavalent vaccine for the treatment of pertussis, diphtheria, tetanus and infection of hemophilia type "In".
One of the main sources of income in Cuba is the biotech industry. The country exports about 38 drugs in 40 countries. According to official data, the industry in 2008 brought 350 or more million dollars. This is about 10 percent of the total annual exports of the country.